FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893112903> ?p ?o ?g. }

• W2893112903 endingPage "126" @default.
• W2893112903 startingPage "120" @default.
• W2893112903 abstract "The aim of the study was to evaluate the impact of disease activity, selected serum cytokines, and therapy on metabolic syndrome (MetS) components in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.We studied 46 SAPHO patients (40 women, 6 men). We recorded age, sex, disease duration, arthritis localization, type of skin changes, bone scintigraphy results, comorbidities, BASDAI, VAS, and treatment. We measured erythrocyte sedimentation rate, C-reactive protein, lipid profile, serum IL-6, IL-18, IL-23, endothelin-1, vascular endothelial growth factor, and epidermal growth factor (EGF).97.8% of patients had sternoclavicular joint arthritis, 91.3% of patients palmoplantar pustulosis. In 65.2% of SAPHO patients skin changes and arthritis started simultaneously. Apart from non-steroidal anti-inflammatory drugs, patients were treated with methotrexate (41.3%), sulfasalazine (41.3%), and antibiotics (39.1%). 19.5% of patients met MetS criteria. Serum IL-23 correlated positively with total cholesterol (TC; p = 0.02) and high-density lipoprotein cholesterol (HDL-C) (p = 0.01) in the SAPHO group. There was a negative correlation between HDL-C and BASDAI (p = 0.02). Patients treated with methotrexate had higher triglyceride (p = 0.01) and low-density lipoprotein cholesterol (LDL-C) (p = 0.01) levels. There was a negative correlation between TC and EGF (p = 0.03). Increased prevalence of autoimmune diseases and depression was observed in SAPHO patients.Serum IL-23 protects, whereas methotrexate treatment stimulates selected components of the MetS in patients with SAPHO syndrome." @default.
• W2893112903 created "2018-10-05" @default.
• W2893112903 creator A5045182020 @default.
• W2893112903 creator A5054404067 @default.
• W2893112903 creator A5057446020 @default.
• W2893112903 date "2021-01-05" @default.
• W2893112903 modified "2023-10-06" @default.
• W2893112903 title "Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome" @default.
• W2893112903 cites W142060821 @default.
• W2893112903 cites W1597643670 @default.
• W2893112903 cites W1855511017 @default.
• W2893112903 cites W1970533537 @default.
• W2893112903 cites W1981396750 @default.
• W2893112903 cites W1991385444 @default.
• W2893112903 cites W2015805011 @default.
• W2893112903 cites W2015868273 @default.
• W2893112903 cites W2016158811 @default.
• W2893112903 cites W2033971898 @default.
• W2893112903 cites W2038880079 @default.
• W2893112903 cites W2058810929 @default.
• W2893112903 cites W2058864885 @default.
• W2893112903 cites W2062403386 @default.
• W2893112903 cites W2068140837 @default.
• W2893112903 cites W2071137198 @default.
• W2893112903 cites W2073612114 @default.
• W2893112903 cites W2078284536 @default.
• W2893112903 cites W2103778140 @default.
• W2893112903 cites W2105813877 @default.
• W2893112903 cites W2132989904 @default.
• W2893112903 cites W2133404675 @default.
• W2893112903 cites W2285175774 @default.
• W2893112903 cites W2397455182 @default.
• W2893112903 cites W2405624971 @default.
• W2893112903 cites W2494435665 @default.
• W2893112903 cites W2560218169 @default.
• W2893112903 cites W2581301907 @default.
• W2893112903 cites W2584833109 @default.
• W2893112903 cites W2588699638 @default.
• W2893112903 cites W2590436023 @default.
• W2893112903 cites W2607031541 @default.
• W2893112903 cites W3028546384 @default.
• W2893112903 cites W31570743 @default.
• W2893112903 cites W4238251256 @default.
• W2893112903 cites W50630657 @default.
• W2893112903 cites W9199335 @default.
• W2893112903 doi "https://doi.org/10.5114/aoms.2018.76953" @default.
• W2893112903 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7811326" @default.
• W2893112903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33488864" @default.
• W2893112903 hasPublicationYear "2021" @default.
• W2893112903 type Work @default.
• W2893112903 sameAs 2893112903 @default.
• W2893112903 citedByCount "1" @default.
• W2893112903 countsByYear W28931129032021 @default.
• W2893112903 crossrefType "journal-article" @default.
• W2893112903 hasAuthorship W2893112903A5045182020 @default.
• W2893112903 hasAuthorship W2893112903A5054404067 @default.
• W2893112903 hasAuthorship W2893112903A5057446020 @default.
• W2893112903 hasBestOaLocation W28931129031 @default.
• W2893112903 hasConcept C126322002 @default.
• W2893112903 hasConcept C134018914 @default.
• W2893112903 hasConcept C141071460 @default.
• W2893112903 hasConcept C203014093 @default.
• W2893112903 hasConcept C2776674182 @default.
• W2893112903 hasConcept C2777077863 @default.
• W2893112903 hasConcept C2778143017 @default.
• W2893112903 hasConcept C2779234776 @default.
• W2893112903 hasConcept C2779244835 @default.
• W2893112903 hasConcept C2779782008 @default.
• W2893112903 hasConcept C2780564577 @default.
• W2893112903 hasConcept C2780578515 @default.
• W2893112903 hasConcept C2781059491 @default.
• W2893112903 hasConcept C2909516574 @default.
• W2893112903 hasConcept C511355011 @default.
• W2893112903 hasConcept C71924100 @default.
• W2893112903 hasConcept C90924648 @default.
• W2893112903 hasConceptScore W2893112903C126322002 @default.
• W2893112903 hasConceptScore W2893112903C134018914 @default.
• W2893112903 hasConceptScore W2893112903C141071460 @default.
• W2893112903 hasConceptScore W2893112903C203014093 @default.
• W2893112903 hasConceptScore W2893112903C2776674182 @default.
• W2893112903 hasConceptScore W2893112903C2777077863 @default.
• W2893112903 hasConceptScore W2893112903C2778143017 @default.
• W2893112903 hasConceptScore W2893112903C2779234776 @default.
• W2893112903 hasConceptScore W2893112903C2779244835 @default.
• W2893112903 hasConceptScore W2893112903C2779782008 @default.
• W2893112903 hasConceptScore W2893112903C2780564577 @default.
• W2893112903 hasConceptScore W2893112903C2780578515 @default.
• W2893112903 hasConceptScore W2893112903C2781059491 @default.
• W2893112903 hasConceptScore W2893112903C2909516574 @default.
• W2893112903 hasConceptScore W2893112903C511355011 @default.
• W2893112903 hasConceptScore W2893112903C71924100 @default.
• W2893112903 hasConceptScore W2893112903C90924648 @default.
• W2893112903 hasIssue "1" @default.
• W2893112903 hasLocation W28931129031 @default.
• W2893112903 hasLocation W28931129032 @default.
• W2893112903 hasLocation W28931129033 @default.
• W2893112903 hasLocation W28931129034 @default.
• W2893112903 hasOpenAccess W2893112903 @default.

• next